Recommendations for the diagnosis of human papilloma virus (HPV) high and low risk in the prevention and treatment of diseases of the oral cavity, pharynx and larynx. Guide of experts PTORL and KIDL

Otolaryngologia Polska

Volumn 67, Issue 3, 2013, Pages 113-134

  Wierzbicka, Małgorzata ^a,b   Józefiak, Agata ^c,d   Szydłowski, Jarosław ^e   Marszałek, Andrzej ^f   Stankiewicz, Czesław ^a   Hassman Poznańska, Elzbieta ^a   Osuch Wójcikiewicz, Ewa ^a   Składzien, Jacek ^a   Klatka, Janusz ^a   Pietruszewska, Wioletta ^a   Puacz, Elzbieta ^c   Szyfter, Krzysztof ^b,g   Szyfter, Witold ^a,b  

^a Polskie Towarzystwo Otolaryngologów Chirurgów Glowy i Szyi   (Poland)

^b Klinika Otolaryngologii i Onkologii Laryngologicznej   (Poland)

^c Krajowa Izba Diagnostów Laboratoryjnych   (Poland)

^d Klinika Otolaryngologii Dzieci cej   (Poland)

^e POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^f NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^g POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Detection; Head and neck cancer; HPV; Molecular diagnosis; Prevalence; Recommendations; Recurrent laryngeal papillomatosis; Screening

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE MARKER; HEAD AND NECK CARCINOMA; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LARYNX DISORDER; LOW RISK POPULATION; MEDICAL SOCIETY; MORBIDITY; MOUTH DISEASE; NONHUMAN; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PHARYNX DISEASE; POLAND; PRACTICE GUIDELINE; RECURRENT RESPIRATORY PAPILLOMATOSIS;

EID: 84880179262     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otpol.2013.01.003     Document Type: Review

References (104)

1. Goździcka-Józefiak A, Kwaśniewska A. Właściwości onkogenne wirusa brodawczaka ludzkiego. W: Spaczyński M, Kȩdzia W, Nowak-Markwitz E, reds. Rak szyjki macicy. Profilaktyka, diagnostyka i leczenie. PZWL: 2009. p. 17-30.
2. Arbyn M, De Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 2012;131(9):1969-1982.
3. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, et al. International classification of diseases for oncology, 3rd ed., Geneva: World Health Organization; 2000.
4. Zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111(6):581-587.
5. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32:59-66.
6. Erdmann J. Recent studies attempt to clarify relationship between oral cancer and human papillomavirus. J Natl Cancer Inst 2003;7(95 (9)):638-639. (Pubitemid 36603710)
7. Nair S, Pillai MR. Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 2005;11(6):350-359. (Pubitemid 41727232)
8. Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 2007;29:779-792. (Pubitemid 47265534)
9. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14(2):467-475. (Pubitemid 40270113)
10. Yang CH, Huang CC, Ko MT, Wei YC, Hwang CF. Human papillomavirus infection and papillary squamous cell carcinoma in the head and neck region. Tumour Biol 2012;12.
11. Rainsbury JW, Ahmed W, Williams HK, Roberts S, Paleri V, Mehanna H. Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis. Head Neck 2012;20.
12. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-1131. (Pubitemid 32285233)
13. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-2623. (Pubitemid 44691317)
14. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006;31:259-266. (Pubitemid 44141088)
15. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008;113:2901-2909.
16. Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP. Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012;571862.
17. Chaturvedi AK. Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol 2012;6:S16-S24.
18. Lassen P. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother Oncol 2010;95(3):371-380.
19. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004;31:744-754. (Pubitemid 39602680)
20. Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 2012;22(2):128-142.
21. Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 2012;122(2):S13-S33.
22. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8:3187-3192. (Pubitemid 35155029)
23. Rosenquist K, Wennerberg J, Schildt EB, Bladstrom A, Goran Hansson B, et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A populationbased case-control study in southern Sweden. Acta Otolaryngol 2005;125:1327-1336. (Pubitemid 41722000)
24. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-1956. (Pubitemid 46740304)
25. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199:1263-1269.
26. Sinha P, Logan HL, Mendenhall WM. Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol 2012;33(1):130-136.
27. Rautava J, Syrjänen S. Human papillomavirus infections in the oral mucosa. J Am Dent Assoc 2011;142(8):905-914.
28. Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2012 [Epub ahead of print].
29. Hartwig S, Syrjänen S, Dominiak-Felden G, Brotons M, Castellsague X. Estimation of the epidemiological burden of human papillomavirus-related cancers and nonmalignant diseases in men in Europe. BMC Cancer 2012;20:12-30.
30. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012;20. http://dx.doi.org/10.1002/hed.22015 [Epub ahead of print].
31. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 2006;135:451-457.
32. Rodu B, Cole P. Oral cavity and pharynx-throat cancer in the United States, 1973-2003. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:653-658.
33. Kingsley K, O'Malley S, Ditmyer M, Chino M. Analysis of oral cancer epidemiology in the US reveals state-specific trends: implications for oral cancer prevention. BMC Public Health 2008;8:87.
34. Szyfter K, Wierzbicka M. Rola wirusa brodawczaka (HPV) w nowotworach głowy i szyi. Postȩpy w chirurgii głowy i szyi 2008;2:41-50.
35. Cole L, Polfus L, Peters ES. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U. S., 1995-2005. PLoS One 2012;7(3).
36. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U. S. population ages 20-44 years. Cancer 2005;103:1843-1849. (Pubitemid 40563256)
37. Brown LM, Check DP, Devesa SS. Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control 2011;22:753-763.
38. Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011;29:1488-1494.
39. Genden EM, Sambur IM, De Almeida JR, Posner M, Rinaldo A, Rodrigo JP. Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol 2012 [Jun. 30, Epub ahead of print].
40. Furniss CS, McClean MD, Smith JF, Bryan J, Nelson HH, et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 2007;120:2386-2392. (Pubitemid 46642125)
41. Joseph AW, D'Souza G. Epidemiology of human papillomavirus-related head and neck cancer. Otolaryngol Clin North Am 2012;45(4):739-764.
42. Campisi G, Giovannelli L. Controversies surrounding human papilloma virus infection, head & neck us oral cancer, implications for prophylaxis and treatment. Head Neck Oncol 2009;30(1):8.
43. Miller DL, Puricelli MD, Stack MS. Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma. Biochem J 2012 15;443(2):339-353.
44. White EA, Kramer RE, Tan MJ, Hayes SD, Harper JW, Howley PM. Comprehensive analysis of host cellular interactions with human papillomavirus e6 proteins identifies new e6 binding partners and reflects viral diversity. J Virol 2012;86(24):13174-13186.
45. Silverman DA, Pitman MJ. Current diagnostic and management trends for recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg 2004;12(6):532-537. (Pubitemid 39565210)
46. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-619. (Pubitemid 351264356)
47. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladström A, et al. Association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a populationbased case-control study in southern Sweden. Acta Otolaryngol 2005;125(12):1337-1344. (Pubitemid 41722001)
48. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121(8):1813-1820. (Pubitemid 47417302)
49. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010;28(27):4142-4148.
50. Syrjänen S, Lodi G, Von Bültzingslöwen I, Aliko A, Arduino P, Campisi G. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011;17(1):58-72.
51. Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol 2011;40(2):489-502.
52. Boy S, Van Rensburg EJ, Engelbrecht S, Dreyer L, Van Heerden M, Van Heerden W. HPV detection in primary intra-oral squamous cell carcinomas-commensal, aetiological agent or contamination? J Oral Pathol Med 2006;35(2):86-90.
53. Kaminagakura E, Villa LL, Andreoli MA, Sobrinho JS, Vartanian JG, Soares FA, et al. High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer 2012 15;130(8):1726-1732.
54. Van Monsjou HS, Van Velthuysen ML, Van Den Brekel MW, Jordanova ES, Melief CJ, Balm AJ. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 2012;130(8):1806-1812.
55. Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 2012;122(7):1558-1565.
56. De Oliveira DE, Bacchi MM, Macarenco RS, Tagliarini JV, Cordeiro RC, Bacchi CE. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol 2006;126(2):284-293. (Pubitemid 44162576)
57. Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope 2009;119(8):1531-1537.
58. Morshed K. Association between human papillomavirus infection and laryngeal squamous cell carcinoma. J Med Virol 2010;82(6):1017-1023.
59. Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 2011;24(10):1295-1305.
60. Stephen JK, Chen KM, Shah V, Havard S, Lu M, Schweitzer VP, et al. Human papillomavirus outcomes in an accessto-care laryngeal cancer cohort. Otolaryngol Head Neck Surg 2012;146(5):730-738.
61. Hoffmann M, Klose N, Gottschlich S, Görögh T, Fazel A, Lohrey C, et al. Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett 2006;239(1):64-70. (Pubitemid 43946576)
62. Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol 2008;2(2):49-59.
63. Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2012;19.
64. Bleyer A. Cancer of the oral cavity and pharynx in young females: increasing incidence, role of human papilloma virus, and lack of survival improvement. Semin Oncol 2009;36(5):451-459.
65. Vageli D, Sourvinos G, Ioannou M, Koukoulis GK, Spandidos DA. High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers 2007;22(4):239-244. (Pubitemid 351256258)
66. Boland JM, McPhail ED, García JJ, Lewis JE, Schembri-Wismayer DJ. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol 2012;25(4):529-536.
67. Descamps G, Duray A, Rodriguez A, Chantrain G, Depuydt CE, Delvenne P, et al. Detection and quantification of human papillomavirus in benign and malignant parotid lesions. Anticancer Res 2012;32(9):3929-3932.
68. Morbini P, Dal Bello B, Alberizzi P, Mannarini L, Mevio N, Bertino G, et al. Exfoliated cells of the oral mucosa for HPV typing by SPF10 in head and neck cancer. J Virol Methods 2012;186(1-2):99-103.
69. Chuang AY, Chuang TC, Chang S, Zhou S, Begum S, Westra WH, et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008;44(10):915-919.
70. Fakhry C, Rosenthal BT, Clark DP, Gillison ML. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila) 2011;4(9):1378-1384.
71. Robinson M, Schache A, Sloan P, Thavaraj S. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol 2012;6(1):S83-S90.
72. D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 2011;53(1):S5-S11.
73. Sanders AE, Slade GD, Patton LL. National prevalence of oral HPV infection and related risk factors in the U. S. adult population. Oral Dis 2012;18(5):430-441.
74. Zur Hausen H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 1986;2(8505):489-491. (Pubitemid 16049520)
75. Syrjanen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol 2003;56(3):174-181. (Pubitemid 36308030)
76. Fields BN, Knipe DM, Howley PM. Fields virology. Philadelphia: Lippincott-Raven Publishers; 1996.
77. Szydłowski J, Pucher B, Walkowiak J. Leczenie nawracaja̧cej brodawczakowatości układu oddechowego. Fam Med 2010;12:958-960.
78. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2003;129(9):976-982. (Pubitemid 37087659)
79. Chesson HW, Forhan SE, Gottlieb SL, Markowitz LE. The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination. Vaccine 2008;26(35):4513-4518.
80. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly suggestive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003;101(4):645-652. (Pubitemid 36390050)
81. Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 2004;130(6):711-716. (Pubitemid 38725044)
82. Gerein V, Soldatski IL, Babkina N, Onufrieva EK, Barysik N, Pfister H. Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation. Int J Pediatr Otorhinolaryngol 2006;70(12):2061-2066. (Pubitemid 44781041)
83. Sinclair KA, Woods CR, Kirse DR, Sinal SH. Anogenital and respiratory tract human papillomavirus infections among children: age, gender and potential transmission through sexual abuse. Pediatrics 2005;116(4):815-825. (Pubitemid 44542805)
84. Kosko JR, Craig S, Derkay S. Role of cesarean section in prevention of recurrent respiratory papillomatosis - is there one? Int J Pediatr Otorhinolaryngol 1996;35(1):31-38. (Pubitemid 26082097)
85. Long YT, Sani A. Recurrent respiratory papillomatosis. Asian J Surg 2003;26(2):112-116. (Pubitemid 36735592)
86. Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Myer CM, et al. Post: age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One 2008;3(5):e2263.
87. Goon P, Sonnex C, Jani P, Stanley M, Sudhoff H. Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol 2008;265(2):147-151.
88. Silver RD, Rimell FL, Adams GL, Derkay CS, Hester R. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 2003;129(6):622-629. (Pubitemid 37509758)
89. Loyo M, Pai SI, Netto GJ, Tunkel DE. Aggressive recurrent respiratory papillomatosis in a neonate. Int J Pediatr Totorhinolaryngol 2008;72(6):917-920.
90. Szyfter W, Wierzbicka M, Jackowska J, Bartochowska A, Banaszewski J. The schedule of intralesional papillomatosis treatment with cidofovir. Otolaryngol Pol 2010;64(2):98-102.
91. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 2012;6(Suppl 1):S104-S120.
92. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and metaanalysis. Oral Oncol 2012;48(12):1191-1201.
93. Lewis Jr JS. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012 Jul; 6(1):S75-S82.
94. Loewenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, et al. New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting. HNO 2012;60(11):951-956.
95. Quon H, Richmon JD. Treatment deintensification strategies for HPV-associated head and neck carcinomas. Otolaryngol Clin North Am 2012;45(4):845-861.
96. Chung CH, Schwartz DL. Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care. Otolaryngol Clin North Am 2012;45(4):795-806.
97. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw 2011;9(6):665-673.
98. Psyrri A, Sasaki C, Vassilakopoulou M, Dimitriadis G, Rampias T. Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck. Head Neck Pathol 2012;6:1.
99. Westra WH. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 2012;6(1):S48-S54.
100. Deng Z, Hasegawa M, Yamashita Y, Matayoshi S, Kiyuna A, Agena S, et al. Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma. Cancer Sci 2012;103(12):2127-2134.
101. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, et al. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 2012;72(19):5004-5013.
102. Wierzbicka M, Jackowska J, Bartochowska A, Józefiak A, Szyfter W, Kȩdzia W. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2011;268(9):1305-1311.
103. Di Lonardo A, Marcante ML, Poggiali F, Venuti A. HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment. J Med Virol 1998;54:192-195. (Pubitemid 28102810)
104. Li W, Thompson CH, O'Brien CJ, McNeil EB, Scolyer RA, Cossart YE, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003;106:553-558. (Pubitemid 36966212)